- Home
- AGEN vs INDO Comparison
AGEN vs INDO Comparison
Compare AGEN & INDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- INDO
- Stock Information
- Founded
- AGEN 1994
- INDO 2018
- Country
- AGEN United States
- INDO Indonesia
- Employees
- AGEN N/A
- INDO N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- INDO Oil & Gas Production
- Sector
- AGEN Health Care
- INDO Energy
- Exchange
- AGEN Nasdaq
- INDO Nasdaq
- Market Cap
- AGEN 38.1M
- INDO 40.1M
- IPO Year
- AGEN 2000
- INDO 2019
- Fundamental
- Price
- AGEN $3.16
- INDO $2.28
- Analyst Decision
- AGEN Buy
- INDO
- Analyst Count
- AGEN 4
- INDO 0
- Target Price
- AGEN $8.00
- INDO N/A
- AVG Volume (30 Days)
- AGEN 655.0K
- INDO 194.5K
- Earning Date
- AGEN 05-06-2025
- INDO 04-29-2025
- Dividend Yield
- AGEN N/A
- INDO N/A
- EPS Growth
- AGEN N/A
- INDO N/A
- EPS
- AGEN N/A
- INDO N/A
- Revenue
- AGEN $103,463,000.00
- INDO $3,127,587.00
- Revenue This Year
- AGEN $4.03
- INDO N/A
- Revenue Next Year
- AGEN $5.57
- INDO N/A
- P/E Ratio
- AGEN N/A
- INDO N/A
- Revenue Growth
- AGEN N/A
- INDO N/A
- 52 Week Low
- AGEN $1.38
- INDO $2.06
- 52 Week High
- AGEN $19.69
- INDO $5.99
- Technical
- Relative Strength Index (RSI)
- AGEN 78.44
- INDO 43.27
- Support Level
- AGEN $1.60
- INDO $2.21
- Resistance Level
- AGEN $1.83
- INDO $2.49
- Average True Range (ATR)
- AGEN 0.31
- INDO 0.16
- MACD
- AGEN 0.21
- INDO -0.00
- Stochastic Oscillator
- AGEN 97.52
- INDO 35.08
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About INDO Indonesia Energy Corporation Limited
Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.